Mutant BRAF has been implicated in the pathogenesis of different types of cancer, including thyroid carcinoma, colorectal carcinoma, non-small cell lung carcinoma, ovarian carcinoma, gliomas, melanoma, and gastrointestinal stromal tumor (GIST) [14]. This evidence concerns the gene BRAF and colorectal carcinoma.